NCT00837629View on ClinicalTrials.gov

Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

743

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00837629 - Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter